SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
Scribe Therapeutics, Inc.
@SCTX_InsiderForm 4 Filing: Avoro Ventures LLC Acquires (Grant) shares of $SCTX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Scribe Therapeutics, Inc.
Ticker: $SCTX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-23
Shares: 14,725
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Avoro Ventures LLC, holds the title of Director at Scribe Therapeutics, Inc..
On 2026-07-23, the insider transacted 14,725 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Avoro Ventures LLC (Director) was granted $0 of $SCTX
Post-Transaction Position: 14,725 shares
SEC Accession No: 0000902664-26-003254 (CIK: 1879253)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.